We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Quick reference materials for primary care on diagnosing and understanding culture results for urinary tract infections (UTI).
Quick reference tools for primary care providers for diagnosing and understanding culture results for urinary tract infections (UTIs).
Strategic behavioural analysis that aims to help understand and change behaviours related to catheter-associated urinary tract infections.
We’re seeking views on updating the diagnosis of urinary tract infections (UTIs) quick reference guide for primary care providers.
This strategic behavioural analysis aims to help understand and change behaviours related to preventing catheter-associated urinary tract infections (CAUTI).
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine vibegron (Obgemsa) to treat the symptoms of overactive bladder (OAB) syndrome in adults. Symptoms may include a sudden need to empty the bladder...
The characteristics, diagnosis, management, surveillance and epidemiology of Escherichia coli (E. coli).
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine capivasertib (Truqap) for patients with advanced hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer which has one or...
The diagnosis, management and surveillance of extended-spectrum beta-lactamases (ESBLs).
The characteristics, diagnosis, management, surveillance and epidemiology Enterococcus species and Glycopeptide Resistant Enterococci (GRE).
The diagnosis and surveillance of Acinetobacter spp. bacteraemia.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).